KOR agonists have received attention in the past due to being non-addictive anti-nociceptive drugs that do not induce respiratory depression (Viscusi et al., 2021; Wang et al., 2021), properties that compare favourably with those of MOR agonists such as morphine. The gene discussed is OPRK1; the disease is respiratory depression.